HZD.L Share News (HZD)

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 2 May Direct Line Insurance GroupQ1 ResultsConvaTec GroupQ1 GroupHalf

Horizon Discovery looks to grow revenue as it teams up with pharmaceutical

(ShareCast News) - Gene editing technology company Horizon Discovery has teamed up with a global pharmaceutical to support its drug discovery developments as it aims to increase revenue in 2017. The AIM-listed company penned a master service agreement with the pharmaceuticals adding to its original

Horizon Discovery's full year revenue rises as volumes increase

(ShareCast News) - Horizon Discovery Group, a maker of gene editing technologies, saw revenue increased last year, driven by better-than-expected sales volumes. For the 2016 calendar year, revenue climbed 19% to £24m compared to the previous year, with gross margin increasing to the mid-50% range, f

Horizon Discovery Targets Positive Earnings In Current Year

Horizon Disc gains Chinese partnerships to develop tumor diagnostic kit

(ShareCast News) - Horizon Discovery, a developer of gene editing technologies, has entered into partnerships with three Chinese diagnostic kit developers to treat tumours. The company will provide HDx Reference Standards for next generation sequencing assay development, clinical trials, and for inc

Horizon Discovery inks subscription-based licensing deal

(ShareCast News) - Horizon Discovery has inked a subscription-based licensing deal for its biomanufacturing cell lines. The deal, the first of its type for the company and with an unnamed commercial partner, is worth a minimum of £500,000. "We look forward to making further announcements in this are

Horizon Discovery Signs Licensing Deal With GBP500,000 Minimum Value

Horizon Discovery Inks CRISPR Platform Deal With Fulcrum Therapeutics

Horizon Discovery signs development agreement with Ventanta

(ShareCast News) - Gene editing technologies company Horizon Discovery Group announced on Thursday that it has entered into a co-development and commercialisation agreement with Ventana Medical Systems, a member of the Roche Group. The AIM-traded firm said the agreement covers the development, manuf

UK Shareholder Meetings Calendar - Next 7 Days

Horizon Discovery Says Qiagen Incorporates Reference Standards

Horizon Discovery Signs Deals With Next Generation Sequencing Firm

BROKER RATINGS SUMMARY: Jefferies And Shore Say Hold AstraZeneca

LONDON BRIEFING: Compass Group Up But TUI Down Following Updates

Revenues grow, losses widen at Horizon Discovery

(ShareCast News) - Gene-editing technology company Horizon Discovery Group saw revenues grow sizably in the 2015 calendar year, it reported on Tuesday, though losses also widened. The AIM-traded firm reported a 69% increase in total group revenue to £20.2m, with product revenues growing 124% to £7.8